ImmunityBio's Soon-Shiong to Join Virtual Oncology Symposium Fireside Chat
ImmunityBio announced that Dr. Patrick Soon-Shiong will participate virtually in a fireside chat at the Piper Sandler Virtual Oncology Symposium. The event is scheduled for October 15-16, 2026. Soon-Shiong is the company's founder, executive chairman, and global chief scientific and medical officer.
... No markdown? Plain text. Good. Need maybe "Soon-Shiong" spelling? We can mention? We didn't mention name. Could mention Dr. Patrick Soon-Shiong? The headline says. The expanded should include factual detail. We can include name. But if we don't, maybe okay. But story is about him. Let's include name? "Dr. Patrick Soon-Shiong" from material. We can say "Dr. Patrick Soon-Shiong, ImmunityBio's founder..." That adds. Need under 120. Let's revise: EXPANDED: ImmunityBio, a Culver City immunotherapy company listed on Nasdaq as IBRX, announced that Dr. Patrick Soon-Shiong will take part remotely in a Piper Sandler Virtual Oncology Symposium fireside chat. He is the company's founder and executive chairman and also serves as its global chief scientific and medical officer. The symposium is scheduled for October 15–16, 2026. The available details are limited: no discussion topics, presentation materials, or other participants were disclosed. The announcement chiefly indicates that a senio